Erratum: Safety comparison between the dpp-4 inhibitor vildagliptin and the sulfonylurea gliclazide after two years of monotherapy in drug-naïve patients with type 2 diabetes (Horm Metab Res (2009) 41 (905-909))

Hormone and Metabolic Research

Volumn 41, Issue 12, 2009, Pages 909-

  Foley, J E ^a   Efficacy, Sreenan S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

EID: 71849083234     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1243513     Document Type: Erratum

References (0)